|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2662091 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13164403.1 |
| Date of filing the European patent application | 2007-11-30 | |
| (97) | Date of publication of the European application | 2013-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (30) | Number | Date | Country code |
| 872170 P | 2006-12-01 | US |
| (72) |
McEver, Rodger P., US
Alvarez, Richard, US
Kawar, Ziad, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Oklahoma Medical Research Foundation, 825 N.E. 13th Street, Oklahoma City, OK 73104, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-P-selektino antikūnai ir jų naudojimo būdai uždegiminių ligų gydymui |
| Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases |
| Payment date | Validity (years) | Amount | |
| 2025-10-23 | 19 | 347.00 EUR |
| 2026-11-30 |